September/October 2016

Biopharma Asia

September/October 2016 | Volume 5 Issue 5


Challenges in the Development of Continuous Processes for Vaccines

By: Daniel C. Vellom, PhD, Senior Director, Global Technology & Innovation Sanofi Pas...


Footprinting our Drugs : Biologics Process Mass Intensity Tool

By: Bonnie Shum, Engineer (DS-MSAT) Kristi Budzinski, Green BioPharma Program ManagerG...


Detection and Management of Protein Aggregation during Downstream Processing

By: Danny K. Chou, Pharm.D., Ph.D., President Compassion Biosolution, LLC


Approaches for Dissolution Prediction of Tablets made by Continuous Manufacturing Direct C...

By: Pallavi Pawar, Post- Doctoral Associate in the Department of Chemical and Biochemica...


Challenges with Measuring Polysorbate levels in Biopharmaceuticals

By: Shiranthi Jayawickreme, Regulatory & Compliance Administrator Duke Cancer Instit...


Productivity and Economic Advantages of Coupling Single-Pass Tangential Flow Filtration to...

By: Mark Schofield, Ph.D., Karl Rogler, Xhorxhi Gjoka, Engin Ayturk, Ph.D., and René Gan...


Get Merck’s winning combination for Environmental Monitoring in Isolators

Merck Millipore